JANELLE ALLANSON: Open Payments
NPI 1790468684 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 50 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $334 |
| E.R. Squibb & Sons, L.L.C. | 14 | $331 |
| Otsuka America Pharmaceutical, Inc. | 8 | $165 |
| Braeburn Inc. | 1 | $115 |
| Alkermes, Inc. | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: COBENFY, UZEDY, REXULTI, BRIXADI, ARISTADA, HETLIOZ, VRAYLAR, CAPLYTA.
Industry payments across NY — which companies pay providers there.
